Marco Taglietti, Scynexis CEO
‘Say no more’ to yeast infections: Scynexis rolls out new Brexafemme marketing — and rallying cry
Scynexis is rolling out a new campaign for its Brexafemme yeast infection treatment, but the effort is more than just advertising.
As CEO Marco Taglietti …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
